DIAGENODE
Grant-FundedCORDISDNA methylation markers to predict treatment success of biologicals in Crohn’s disease.
AI / ML
DIAGENODE is a private SME recorded in CORDIS in Belgium, with participation in 20 EU research and innovation projects. Its recorded projects include “DNA methylation markers to predict treatment success of biologicals in Crohn’s disease.”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
EU Grants€5,691,069
All-time revenue—
MRRPrivate••••••
Founder—
Founded—
🇧🇪Belgium
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics
Startup insights
Value proposition
DIAGENODE is a private SME recorded in CORDIS in Belgium, with participation in 20 EU research and innovation projects. Its recorded projects include “DNA methylation markers to predict treatment success of biologicals in Crohn’s disease.”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
AI / ML
Tags:AI / ML
Company Info
DIAGENODE Info
Funding
EU Grants€5,691,069